Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Adult
Aged
Aged, 80 and over
Female
Humans
Hydronephrosis
/ etiology
Male
Middle Aged
Multivariate Analysis
Retrospective Studies
Stents
Survival Rate
Treatment Failure
Treatment Outcome
Ureter
/ surgery
Ureteral Obstruction
/ mortality
Urinary Bladder Neoplasms
/ pathology
Uterine Cervical Neoplasms
/ pathology
Malignant extrinsic ureteral obstruction
Predictive factors
Stent failure
Ureteral stent
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
18
07
2018
accepted:
22
09
2018
pubmed:
10
10
2018
medline:
30
5
2019
entrez:
10
10
2018
Statut:
ppublish
Résumé
This study investigated the clinical outcomes of stent placement for malignant extrinsic ureteral obstruction (MUO) and predictive factors for stent failure. We retrospectively analyzed clinical data for 91 patients with radiologically significant hydronephrosis due to MUO who underwent successful stent placement. In total, 132 ureters were stented for the decompression. Factors related to stent failure were analyzed with a Cox proportional hazards model. Stent failure occurred in 25 ureters in 20 patients. The median interval to failure was 63 days. The multivariate analysis showed that the significant predictors of stent failure were bladder invasion and severe hydronephrosis before the stent insertion. The patients were divided into three groups based on these two factors: low-risk (neither factor; 85 patients), intermediate-risk (one factor; 37), and high-risk (both factors; 10). The median stent failure-free survival rate at 3 months was 94.8% in the low-risk, 71.8% in the intermediate-risk and 55.6% in the high-risk group, respectively. Of the ureters with stent failure, there was successful re-replacement of internal stents in 3 low-risk, 6 intermediate-risk and no high-risk ureters. Replacement by nephrostomy was done in 2 low-risk, 5 intermediate-risk and 7 high-risk ureters. The patients considered at low-risk could be managed without stent failure by internal stenting. However, the patients at high-risk may require the consideration of nephrostomy or other alternatives as the initial treatment. Our stratification model may allow better risk stratification for patients with regard to ureteral stenting, helping to identify patients for whom ureteral stenting is indicated.
Sections du résumé
BACKGROUND
BACKGROUND
This study investigated the clinical outcomes of stent placement for malignant extrinsic ureteral obstruction (MUO) and predictive factors for stent failure.
METHODS
METHODS
We retrospectively analyzed clinical data for 91 patients with radiologically significant hydronephrosis due to MUO who underwent successful stent placement. In total, 132 ureters were stented for the decompression. Factors related to stent failure were analyzed with a Cox proportional hazards model.
RESULTS
RESULTS
Stent failure occurred in 25 ureters in 20 patients. The median interval to failure was 63 days. The multivariate analysis showed that the significant predictors of stent failure were bladder invasion and severe hydronephrosis before the stent insertion. The patients were divided into three groups based on these two factors: low-risk (neither factor; 85 patients), intermediate-risk (one factor; 37), and high-risk (both factors; 10). The median stent failure-free survival rate at 3 months was 94.8% in the low-risk, 71.8% in the intermediate-risk and 55.6% in the high-risk group, respectively. Of the ureters with stent failure, there was successful re-replacement of internal stents in 3 low-risk, 6 intermediate-risk and no high-risk ureters. Replacement by nephrostomy was done in 2 low-risk, 5 intermediate-risk and 7 high-risk ureters.
CONCLUSION
CONCLUSIONS
The patients considered at low-risk could be managed without stent failure by internal stenting. However, the patients at high-risk may require the consideration of nephrostomy or other alternatives as the initial treatment. Our stratification model may allow better risk stratification for patients with regard to ureteral stenting, helping to identify patients for whom ureteral stenting is indicated.
Identifiants
pubmed: 30298199
doi: 10.1007/s10147-018-1348-6
pii: 10.1007/s10147-018-1348-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
306-312Références
Cancer. 1999 Feb 15;85(4):998-1003
pubmed: 10091780
J Urol. 2001 Nov;166(5):1746-9
pubmed: 11586215
J Urol. 2004 Aug;172(2):592-5
pubmed: 15247739
J Urol. 2005 Dec;174(6):2125-8
pubmed: 16280741
J Endourol. 2008 Feb;22(2):295-9
pubmed: 18294036
Urology. 2008 Aug;72(2):370-3
pubmed: 18336878
J Urol. 2008 Aug;180(2):618-21; discussion 621
pubmed: 18554655
J Urol. 2011 Feb;185(2):556-61
pubmed: 21168872
Int J Urol. 2011 May;18(5):379-82
pubmed: 21518020
Korean J Urol. 2013 May;54(5):316-21
pubmed: 23700497
Int Braz J Urol. 2014 Mar-Apr;40(2):225-31
pubmed: 24856490
BJU Int. 2016 Feb;117(2):266-71
pubmed: 25327474
J Urol. 2015 Apr;193(4):1092-100
pubmed: 25463984
Indian J Urol. 2015 Jan-Mar;31(1):8-14
pubmed: 25624569
Int J Urol. 2015 Jul;22(7):629-36
pubmed: 25950837
Hippokratia. 2014 Oct-Dec;18(4):292-7
pubmed: 26052193
PLoS One. 2015 Aug 12;10(8):e0135566
pubmed: 26267140
J Pain Symptom Manage. 2016 Feb;51(2):255-61
pubmed: 26497918
Oncol Lett. 2016 Jan;11(1):879-883
pubmed: 26870299
World J Nephrol. 2016 Mar 6;5(2):172-81
pubmed: 26981442
Asian J Urol. 2016 Jul;3(3):142-149
pubmed: 29264182
Cancer. 1987 Sep 15;60(6):1353-7
pubmed: 3621117